MA42889B2 - Triple activator activating the glucagon, glp-1 and gip receptor - Google Patents

Triple activator activating the glucagon, glp-1 and gip receptor

Info

Publication number
MA42889B2
MA42889B2 MA42889A MA42889A MA42889B2 MA 42889 B2 MA42889 B2 MA 42889B2 MA 42889 A MA42889 A MA 42889A MA 42889 A MA42889 A MA 42889A MA 42889 B2 MA42889 B2 MA 42889B2
Authority
MA
Morocco
Prior art keywords
glp
glucagon
gip receptor
triple activator
activator activating
Prior art date
Application number
MA42889A
Other languages
French (fr)
Other versions
MA42889A1 (en
Inventor
Sung Youb Jung
Euh Lim Oh
Chang Ki Lim
Se Chang Kwon
Young Jin Park
Jong Suk Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Priority claimed from PCT/KR2016/015554 external-priority patent/WO2017116204A1/en
Publication of MA42889A1 publication Critical patent/MA42889A1/en
Publication of MA42889B2 publication Critical patent/MA42889B2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne un triple activateur qui active le récepteur du glucagon, du glp-1 et du gip, et des applications de ce triple activateur.The present invention relates to a triple activator which activates the receptor for glucagon, glp-1 and gip, and applications of this triple activator.

MA42889A 2015-12-31 2016-12-30 Triple activator activating the glucagon, glp-1 and gip receptor MA42889B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150191082 2015-12-31
PCT/KR2016/015554 WO2017116204A1 (en) 2015-12-31 2016-12-30 Triple activator activating glucagon, glp-1 and gip receptor

Publications (2)

Publication Number Publication Date
MA42889A1 MA42889A1 (en) 2018-11-30
MA42889B2 true MA42889B2 (en) 2020-11-30

Family

ID=62104015

Family Applications (4)

Application Number Title Priority Date Filing Date
MA42889A MA42889B2 (en) 2015-12-31 2016-12-30 Triple activator activating the glucagon, glp-1 and gip receptor
MA42891A MA42891B2 (en) 2015-12-31 2016-12-30 Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor
MA51955A MA51955B1 (en) 2015-12-31 2016-12-30 Triple activator activating glucagon, glp-1 and gip receptor
MA53533A MA53533A1 (en) 2015-12-31 2018-07-26 Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor

Family Applications After (3)

Application Number Title Priority Date Filing Date
MA42891A MA42891B2 (en) 2015-12-31 2016-12-30 Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor
MA51955A MA51955B1 (en) 2015-12-31 2016-12-30 Triple activator activating glucagon, glp-1 and gip receptor
MA53533A MA53533A1 (en) 2015-12-31 2018-07-26 Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor

Country Status (3)

Country Link
AR (2) AR107282A1 (en)
MA (4) MA42889B2 (en)
MY (1) MY199261A (en)

Also Published As

Publication number Publication date
MA42891B2 (en) 2021-11-30
MA51955A1 (en) 2021-10-29
MY199261A (en) 2023-10-23
MA53533A1 (en) 2022-08-31
AR107281A1 (en) 2018-04-18
AR107282A1 (en) 2018-04-18
MA42891A1 (en) 2019-04-30
MA42889A1 (en) 2018-11-30
MA51955B1 (en) 2022-04-29

Similar Documents

Publication Publication Date Title
PH12018501409A1 (en) Triple glucagon/glp-1/gip receptor agonist
MX2020009649A (en) Monoclonal antibodies against bcma.
MA49545B1 (en) Glucagon derivative and composition comprising a long-acting conjugate thereof
MX2018006148A (en) Inhibitors of cxcr2.
PE20180395A1 (en) SOLID DOSAGE FORMS OF PALBOCICLIB
MX2020003217A (en) Long-acting co-agonists of the glucagon and glp-1 receptors.
EA201792612A1 (en) 6-AMINOHINOLIN-3-CARBONITRILES AS COT MODULATORS
CL2019003599S1 (en) Extinguisher.
WO2017074798A3 (en) Long-acting co-agonists of the glucagon and glp-1 receptors
EA201890828A1 (en) OPTIMIZED TABLET WITH HIGH DOSE OF ACTIVE COMPOUND, CONTAINING MESALAZIN
TR201901228T4 (en) Vortioxetine pyroglutamate.
EA201792527A1 (en) TREATMENT OF ZUD
MA42889B2 (en) Triple activator activating the glucagon, glp-1 and gip receptor
ECSP17085737A (en) SOLID DOSAGE FORMS OF PALBOCICLIB
EA201991993A1 (en) APPLICATION OF PHENYLCREATIN AS A NOOTROPIC AGENT
CL2015000874A1 (en) Pde9i with main structure of imidazopirazinone
UA104671U (en) Application of iakton as neuroprotective agents.
UA101750U (en) Use of omega as organoprotector in toxic hepatitis
TN2014000522A1 (en) لوح مدرسي بوجهين
UA100710U (en) APPLICATION OF FITOVENOL Capsules AS A HEPATOPROTECTOR
TN2014000377A1 (en) طائرة كهربائية كاتمة للصوت